01 Apr, 2020
Biogen Inc. (NASDAQ: BIIB) Alzheimer’s drug aducanumab or “Aduhelm” was approved by the Food and Drug Administration (FDA) this morning. Aduhelm is the first drug cleared by the FDA to help fight Alzheimer’s in almost 20 year..
Pfizer Inc. (NYSE: PFE), The Israel Ministry of Health and BioNTech SE (NASDAQ: BNTX) reported evidence that demonstrates lower incidence rates of COVID-19 disease in individuals that are vaccinated with BNT162b2. The new data confirms previou..
iBio, Inc. (NYSE: IBIO) announced Thursday that immunization studies for its SARS-CoV-2 Virus-Like Particle (“VLP”) program (“IBIO-200”) are proceeding at Texas A&M University System (“TAMUS”) laboratories. Ac..
Hoth Therapeutics, Inc. (NASDAQ: HOTH) shares spiked about 90% Monday morning after the biopharmaceutical company announced that it has reached an agreement with Voltron Therapeutics, Inc. to form a joint venture entity, to be named HaloVax, which w..
Pfizer Inc. (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) today announced that the companies have agreed to a letter of intent regarding the co-development and distribution (excluding China) of a potential mRNA-based coronavirus vaccine aimed at preven..
BioNTech SE (NASDAQ: BNTX) and Shanghai Fosun Pharmaceutical (Group) Co., Ltd (“Fosun Pharma” or “Group”; Stock Symbol: 600196.SH, 02196.HK) announced today a strategic development and commercialization collaboration to advan..
BioXcel Therapeutics, Inc. (NASDAQ: BTAI) reported fourth quarter and full year ended December 31st, 2019 financial results. BXCL501 is designed for the treatment of acute agitation. The company initiated phase 3 trials for acute tr..
All rights reserved.
No portion of Financialinsiders.com may be duplicated, redistributed or manipulated in any form without our consent, violators will be prosecuted to the full extent of the law. By accessing any information beyond this page, you agree to abide by the Privacy Policy and Terms of Use (Disclaimer).